Whitehawk Therapeutics (WHWK) Inventory Average (2022 - 2024)
Historic Inventory Average for Whitehawk Therapeutics (WHWK) over the last 3 years, with Q4 2024 value amounting to $5.4 million.
- Whitehawk Therapeutics' Inventory Average rose 733.92% to $5.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.4 million, marking a year-over-year increase of 733.92%. This contributed to the annual value of $5.9 million for FY2024, which is 4162.64% up from last year.
- Latest data reveals that Whitehawk Therapeutics reported Inventory Average of $5.4 million as of Q4 2024, which was up 733.92% from $5.8 million recorded in Q3 2024.
- Over the past 5 years, Whitehawk Therapeutics' Inventory Average peaked at $6.2 million during Q1 2024, and registered a low of $464500.0 during Q2 2022.
- In the last 3 years, Whitehawk Therapeutics' Inventory Average had a median value of $3.6 million in 2023 and averaged $3.7 million.
- As far as peak fluctuations go, Whitehawk Therapeutics' Inventory Average soared by 68148.55% in 2023, and later soared by 733.92% in 2024.
- Whitehawk Therapeutics' Inventory Average (Quarter) stood at $1.3 million in 2022, then soared by 286.97% to $5.0 million in 2023, then grew by 7.34% to $5.4 million in 2024.
- Its Inventory Average stands at $5.4 million for Q4 2024, versus $5.8 million for Q3 2024 and $6.0 million for Q2 2024.